Background As the third-generation tension-free tape for female stress urinary incontinence （SUI）, tension-free vaginal tape （TVT）-Secur has decreased the common complications associated with TVT and tension-free ...Background As the third-generation tension-free tape for female stress urinary incontinence （SUI）, tension-free vaginal tape （TVT）-Secur has decreased the common complications associated with TVT and tension-free vaginal tape-transobturator （TVT-O）, such as bladder perforation and obstruction of the bladder outlet; but its efficacy and persistence were still controversial. The aim of this study was to prospectively evaluate and compare the postoperative efficacy and complication at different follow-up time.Methods Patients with SUI, who underwent lVT-Secur treatment in two hospitals from October 2008 to October 2009,were selected. By analyzing preoperative and intraoperative data and postoperative complications, the therapeutic effect and satisfaction at different follow-up stages were evaluated.Results A total of 30 female patients participated in this study. Patients were scheduled for follow-up at the 1st month,3rd month, 6th month and 12th month, while the cure rate was 83.3% （25 patients）, 66.7% （20 patients）, 63.3% （19patients） and 60.0% （18 patients） respectively and the overactive bladder （OAB） symptoms appeared in 11 patients （36.7%）, 10 patients （33.3%）, 6 patients （20%） and 7 patients （23.3%） respectively.Conclusion With the follow-up time becoming longer, TVT-Secur has a high recurrence rate of SUI, the therapeutic effect from the 3rd month to the 12th month is relatively persistent.展开更多
文摘Background As the third-generation tension-free tape for female stress urinary incontinence （SUI）, tension-free vaginal tape （TVT）-Secur has decreased the common complications associated with TVT and tension-free vaginal tape-transobturator （TVT-O）, such as bladder perforation and obstruction of the bladder outlet; but its efficacy and persistence were still controversial. The aim of this study was to prospectively evaluate and compare the postoperative efficacy and complication at different follow-up time.Methods Patients with SUI, who underwent lVT-Secur treatment in two hospitals from October 2008 to October 2009,were selected. By analyzing preoperative and intraoperative data and postoperative complications, the therapeutic effect and satisfaction at different follow-up stages were evaluated.Results A total of 30 female patients participated in this study. Patients were scheduled for follow-up at the 1st month,3rd month, 6th month and 12th month, while the cure rate was 83.3% （25 patients）, 66.7% （20 patients）, 63.3% （19patients） and 60.0% （18 patients） respectively and the overactive bladder （OAB） symptoms appeared in 11 patients （36.7%）, 10 patients （33.3%）, 6 patients （20%） and 7 patients （23.3%） respectively.Conclusion With the follow-up time becoming longer, TVT-Secur has a high recurrence rate of SUI, the therapeutic effect from the 3rd month to the 12th month is relatively persistent.
